Browsing ICR Divisions by author "Cheng, Leslie"
Now showing items 1-1 of 1
-
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer - Real-World Outcomes From UK Centres.
Lorimer, C; Cheng, L; Chandler, R; Garcez, K; Gill, V; et al. (ELSEVIER SCIENCE LONDON, 2022-11-12)AIMS: Anaplastic thyroid cancer (ATC) is a rare but aggressive form of thyroid cancer with a median survival of 4 months. Recent advances in molecular profiling have shown that up to half of ATCs harbour the BRAF-V600E ...